Screener
Vir Biotechnology, Inc. VIR Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Vir Biotechnology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:MarketableSecuritiesCurrent.
The source filing: Vir Biotechnology, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 5:20 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053549
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| ASSETS | ||
| CURRENT ASSETS: | ||
| Cash and cash equivalents | $278,729 | $232,185 |
| Short-term investments | 249,864 | 228,753 |
| Restricted cash and cash equivalents, current | 1,929 | 1,922 |
| Equity investments | 4,133 | 6,077 |
| Prepaid expenses and other current assets | 39,084 | 45,143 |
| Total current assets | 573,739 | 514,080 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Vir Biotechnology, Inc.'s short-term investments?
- Vir Biotechnology, Inc. (VIR) reported short-term investments of $249.86M in Q2 2026.
- How has Vir Biotechnology, Inc.'s short-term investments changed year-over-year?
- Vir Biotechnology, Inc.'s short-term investments decreased by 35.5% year-over-year, from $387.65M to $249.86M.
- What is the long-term trend for Vir Biotechnology, Inc.'s short-term investments?
- Over 5 years (2020 to 2025), Vir Biotechnology, Inc.'s short-term investments has grown at a -5.3% compound annual growth rate (CAGR), from $300.29M to $228.75M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.
Ask your AI about Vir Biotechnology, Inc.'s short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude